comparemela.com

Latest Breaking News On - Tom wiggans - Page 5 : comparemela.com

Pardes Biosciences (PRDS) Appoints Laurie Smaldone Alsup and John C. Pottage to its Board

Pardes Biosciences (PRDS) Appoints Laurie Smaldone Alsup and John C. Pottage to its Board
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United-states
American
Pardes-biosciences
Laurie-smaldone-alsup
Tom-wiggans
Smaldone-alsup
Vertex-pharmaceuticals-inc
Drug-development-of-achillion-pharmaceuticals-inc
Arvinas-inc
Infectious-disease-clinical-research
Nasdaq
Pfizer-inc

Pardes Biosciences Appoints Laurie Smaldone Alsup, M.D. and John C. Pottage, Jr., M.D. to Board of Directors

Pardes Biosciences Appoints Laurie Smaldone Alsup, M.D. and John C. Pottage, Jr., M.D. to Board of Directors - read this article along with other careers information, tips and advice on BioSpace

United-states
American
Pardes-biosciences
Laurie-smaldone-alsup
Stephen-jasper
Patrick-obrien
Tom-wiggans
Smaldone-alsup
Vertex-pharmaceuticals-inc
Drug-development-of-achillion-pharmaceuticals-inc
Arvinas-inc
Infectious-disease-clinical-research

Pardes Biosciences Announces Commencement of Phase 2 Trial Evaluating PBI-0451 for the Treatment of SARS-CoV-2 Infections

Phase 2 trial expected to enroll 210 patients at approximately 75 sites to evaluate antiviral activity, safety, and efficacy of PBI-0451 versus placebo Interim data from Phase 2 anticipated in Q1. | September 13, 2022

United-states
Pardes-biosciences
Stephen-jasper
Patrick-obrien
Pardes-bioscience
Tom-wiggans
Exchange-commission
Gilmartin-group
Pardes-biosciences-inc
Nasdaq
Globenewswire-inc
Chief-executive-officer

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.